Correlation Between NORFOLK and Lipocine
Specify exactly 2 symbols:
By analyzing existing cross correlation between NORFOLK SOUTHN P and Lipocine, you can compare the effects of market volatilities on NORFOLK and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NORFOLK with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of NORFOLK and Lipocine.
Diversification Opportunities for NORFOLK and Lipocine
Modest diversification
The 3 months correlation between NORFOLK and Lipocine is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding NORFOLK SOUTHN P and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and NORFOLK is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NORFOLK SOUTHN P are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of NORFOLK i.e., NORFOLK and Lipocine go up and down completely randomly.
Pair Corralation between NORFOLK and Lipocine
Assuming the 90 days trading horizon NORFOLK is expected to generate 6.57 times less return on investment than Lipocine. But when comparing it to its historical volatility, NORFOLK SOUTHN P is 19.39 times less risky than Lipocine. It trades about 0.01 of its potential returns per unit of risk. Lipocine is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 917.00 in Lipocine on October 26, 2024 and sell it today you would lose (448.00) from holding Lipocine or give up 48.85% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 78.54% |
Values | Daily Returns |
NORFOLK SOUTHN P vs. Lipocine
Performance |
Timeline |
NORFOLK SOUTHN P |
Lipocine |
NORFOLK and Lipocine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NORFOLK and Lipocine
The main advantage of trading using opposite NORFOLK and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NORFOLK position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.NORFOLK vs. AEP TEX INC | NORFOLK vs. US BANK NATIONAL | NORFOLK vs. Albertsons Companies | NORFOLK vs. Innovation Beverage Group |
Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Valuation Check real value of public entities based on technical and fundamental data |